PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+13.16%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$87.2M
AUM Growth
+$87.2M
(+9.2%)
Cap. Flow
-$2.86M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
132
New
15
Increased
18
Reduced
52
Closed
16
Top Buys
| 1 |
Boston Scientific
BSX
|
$1.18M |
| 2 |
SNAK
Inventure Foods, Inc.
SNAK
|
$1.05M |
| 3 |
H.B. Fuller
FUL
|
$823K |
| 4 |
VYNT
Vyant Bio, Inc. Common Stock
VYNT
|
$789K |
| 5 |
Cantaloupe
CTLP
|
$776K |
Top Sells
| 1 |
Plus Therapeutics
PSTV
|
$2.53M |
| 2 |
NSPH
NANOSPHERE INC. COM NEW
NSPH
|
$2.15M |
| 3 |
STJ
St Jude Medical
STJ
|
$1.5M |
| 4 |
HDS
HD Supply Holdings, Inc.
HDS
|
$1.25M |
| 5 |
Fastenal
FAST
|
$1.22M |
Sector Composition
| 1 | Healthcare | 57.65% |
| 2 | Technology | 11.04% |
| 3 | Industrials | 7.97% |
| 4 | Consumer Staples | 5.32% |
| 5 | Communication Services | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NeoGenomics
NEO
$1.13B
| $5.41M | 6.2% | 673,032 -24,450 | -4% | -$197K |
|
|
STJ
2
DELISTED
St Jude Medical
STJ
| $5.2M | 5.96% | 66,673 -19,265 | -22% | -$1.5M |
|
3
Axogen
AXGN
$743M
| $4.35M | 4.98% | 631,908 -1,225 | -0.2% | -$8.43K |
|
4
Rockwell Medical
RMTI
$58.9M
| $3.62M | 4.15% | 478,650 +100 | +0% | +$757 |
|
5
Altimmune
ALT
$338M
| $2.11M | 2.42% | 864,000 -89,800 | -9% | -$219K |
|
|
CSII
6
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.05M | 2.35% | 111,600 +16,900 | +18% | +$311K |
|
7
LeMaitre Vascular
LMAT
$2.16B
| $1.97M | 2.26% | 138,358 -7,540 | -5% | -$108K |
|
|
BEAT
8
DELISTED
BioTelemetry, Inc.
BEAT
| $1.96M | 2.25% | 120,250 | – | – |
|
9
Pfizer
PFE
$141B
| $1.96M | 2.25% | 55,629 -6,050 | -10% | -$213K |
|
10
ePlus
PLUS
$1.93B
| $1.81M | 2.07% | 22,100 -1,000 | -4% | -$81.8K |
|
|
SNAK
11
DELISTED
Inventure Foods, Inc.
SNAK
| $1.56M | 1.79% | 199,750 +134,250 | +205% | +$1.05M |
|
12
Eli Lilly
LLY
$657B
| $1.55M | 1.78% | 19,700 | – | – |
|
13
IZEA Worldwide
IZEA
$64.3M
| $1.49M | 1.71% | 196,035 +52,850 | +37% | +$403K |
|
|
QUMU
14
DELISTED
Qumu Corp.
QUMU
| $1.33M | 1.53% | 300,010 +164,010 | +121% | +$728K |
|
15
Idexx Laboratories
IDXX
$51.8B
| $1.3M | 1.49% | 14,000 | – | – |
|
16
LifeVantage
LFVN
$165M
| $1.27M | 1.46% | 93,482 | – | – |
|
|
SVU
17
DELISTED
SUPERVALU Inc.
SVU
| $1.23M | 1.41% | 260,150 -4,000 | -2% | -$18.9K |
|
18
AT&T
T
$209B
| $1.21M | 1.39% | 28,062 -1,500 | -5% | -$64.8K |
|
19
AtriCure
ATRC
$1.84B
| $1.2M | 1.38% | 85,100 +900 | +1% | +$12.7K |
|
20
Altria Group
MO
$113B
| $1.2M | 1.38% | 17,400 -1,000 | -5% | -$69K |
|
21
IRIDEX
IRIX
$22.8M
| $1.2M | 1.37% | 80,800 +21,000 | +35% | +$311K |
|
|
22
Boston Scientific
BSX
$156B
| $1.18M | 1.36% | +50,650 | New | +$1.18M |
|
|
VYNT
23
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.16M | 1.33% | 581,200 +396,250 | +214% | +$789K |
|
|
ZIXI
24
DELISTED
Zix Corporation
ZIXI
| $1.14M | 1.3% | 303,539 -5,500 | -2% | -$20.6K |
|
|
TEAR
25
DELISTED
TearLab Corporation
TEAR
| $1.12M | 1.29% | 1,755,242 +483,500 | +38% | +$309K |
|